D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$751M |
| 2 |
Advanced Micro Devices
AMD
|
+$751M |
| 3 |
Micron Technology
MU
|
+$426M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$363M |
| 5 |
ExxonMobil
XOM
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$336M |
| 5 |
UnitedHealth
UNH
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.03% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Healthcare | 5.76% |
| 4 | Financials | 5.47% |
| 5 | Communication Services | 4.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AEL
2401
DELISTED
American Equity Investment Life Holding Company
AEL
| $2.35M | ﹤0.01% |
42,073
-80,373
| -66% | -$4.37M |
|
2402
Vishay Precision Group
VPG
$1.12B
| $2.34M | ﹤0.01% |
68,784
+17,064
| +33% | +$535K |
|
2403
Skywest
SKYW
$4.39B
| $2.34M | ﹤0.01% |
44,856
-4,782
| -10% | -$215K |
|
2404
CRISPR Therapeutics
CRSP
$4.66B
| $2.33M | ﹤0.01% |
+37,272
| New | +$2.06M |
|
2405
EyePoint Inc
EYPT
$982M
| $2.33M | ﹤0.01% |
+100,960
| New | +$1.13M |
|
2406
PUT
Sun Life Financial
SLF
$45.8B
| $2.33M | ﹤0.01% |
+45,000
| New | +$2.21M |
|
2407
Arcturus Therapeutics
ARCT
$161M
| $2.33M | ﹤0.01% |
73,795
+29,166
| +65% | +$693K |
|
|
THS
2408
DELISTED
Treehouse Foods
THS
| $2.33M | ﹤0.01% |
56,110
+19,987
| +55% | +$820K |
|
|
FYBR
2409
DELISTED
Frontier Communications
FYBR
| $2.32M | ﹤0.01% |
+91,698
| New | +$1.85M |
|
2410
Quetta Acquisition Corp
QETA
| $2.32M | ﹤0.01% |
+230,000
| New | +$2.32M |
|
|
CALY
2411
PUT
Callaway Golf Company
CALY
$3.25B
| $2.32M | ﹤0.01% |
+161,800
| New | +$2.08M |
|
2412
PUT
Citizens Financial Group
CFG
$30.7B
| $2.32M | ﹤0.01% |
+70,000
| New | +$1.93M |
|
2413
PUT
Darden Restaurants
DRI
$24.2B
| $2.32M | ﹤0.01% |
+14,100
| New | +$2.13M |
|
2414
Nektar Therapeutics
NKTR
$2.33B
| $2.32M | ﹤0.01% |
273,256
-134,946
| -33% | -$1.02M |
|
2415
Ingles Markets
IMKTA
$1.74B
| $2.31M | ﹤0.01% |
26,749
+6,593
| +33% | +$537K |
|
2416
PUT
Vertiv
VRT
$89.5B
| $2.31M | ﹤0.01% |
48,100
+18,100
| +60% | +$771K |
|
2417
U-Haul Holding Co
UHAL
$14.2B
| $2.31M | ﹤0.01% |
32,147
+1,072
| +3% | +$60.8K |
|
2418
CALL
Johnson Controls International
JCI
$84.1B
| $2.31M | ﹤0.01% |
+40,000
| New | +$2.1M |
|
2419
Melco Resorts & Entertainment
MLCO
$2.2B
| $2.3M | ﹤0.01% |
259,279
+45,418
| +21% | +$370K |
|
2420
Dolby
DLB
$5B
| $2.29M | ﹤0.01% |
26,574
+3,297
| +14% | +$278K |
|
2421
AudioCodes
AUDC
$241M
| $2.29M | ﹤0.01% |
189,510
+5,734
| +3% | +$58.7K |
|
2422
CTS Corp
CTS
$1.81B
| $2.29M | ﹤0.01% |
52,276
-5,783
| -10% | -$233K |
|
2423
REX American Resources
REX
$1.4B
| $2.29M | ﹤0.01% |
+96,638
| New | +$1.93M |
|
2424
Rackspace Technology
RXT
$962M
| $2.28M | ﹤0.01% |
1,141,176
+501,214
| +78% | +$757K |
|
2425
Angi Inc
ANGI
$253M
| $2.28M | ﹤0.01% |
91,512
+30,420
| +50% | +$621K |
|
Similar funds
D.E. Shaw & Co's Q4 2023 Portfolio in Review
As of Q4 2023, D.E. Shaw & Co held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
- D.E. Shaw & Co added most to Netflix in Q4 2023, an estimated $751M increase.
- D.E. Shaw & Co's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
- D.E. Shaw & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
- D.E. Shaw & Co opened 575 new positions and closed 527 in Q4 2023.
- D.E. Shaw & Co's portfolio value rose 19% quarter-over-quarter to $114B.
Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.